Jubilant Pharmova Limited has intimated the stock exchanges about an upcoming meeting of its Board of Directors. The meeting is scheduled to be held on Friday, August 07, 2026.
The primary agenda of the board meeting is to consider and approve the Un-audited Standalone and Consolidated Financial Results of the Company for the quarter ended June 30, 2026 (Q1 FY27).
This intimation is made in compliance with Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations').
The company will simultaneously post the financial results document on its official website at www.jubilantpharmova.com following the board meeting.
The communication was digitally signed by Naresh Kapoor, Company Secretary of Jubilant Pharmova Limited, on July 30, 2026 at 17:30:54 IST.